インデックス付き
- Jゲートを開く
- Genamics JournalSeek
- アカデミックキー
- ジャーナル目次
- 研究聖書
- 電子ジャーナルライブラリ
- レフシーク
- ハムダード大学
- エブスコ アリゾナ州
- OCLC-WorldCat
- プロクエスト召喚
- SWBオンラインカタログ
- 仮想生物学図書館 (vifabio)
- パブロン
- ミアル
- ユーロパブ
- Google スカラー
このページをシェアする
ジャーナルチラシ
概要
Pharmacogenomics- Personalized Treatment of Cancer, Diabetes and Cardiovascular Diseases
Nishant Toomula, Hima Bindu K, Sathish Kumar D and Arun Kumar R
Pharmacogenomics is the study of genetic variations between individuals to predict the risk of toxic side effects and the probability that a patient will respond to single or multiple drug treatment. The ways people respond to drugs are complex traits that are influenced by many different genes. Pharmacogenomics intends to develop rational means of optimizing drug therapy, with respect to the patientsâ genotype, to maximize efficacy with minimal adverse drug reactions. Pharmacogenomics has the potential to revolutionize the practice of medicine, and promises to guide in an area of personalized medicine, in which drugs and drug combinations are optimized for each individualâs unique genetic makeup. This review gives information regarding principles of pharmacogenomics and how pharmacogenomics can advance the development of personalized treatments by revealing genetic variations that predict individual responses to therapeutic interventions.